Ken Ng - researchr alias

researchr

You are not signed in
Sign in
Sign up

Viewing Publication 1 - 3 from 3

2020

Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interfaceJulia Liang, Chris Karagiannis, Eleni Pitsillou, Kevion K. Darmawan, Ken Ng, Andrew Hung, Tom C. Karagiannis. CANDC, 89:107372, 2020. [doi]

Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complexJulia Liang, Eleni Pitsillou, Chris Karagiannis, Kevion K. Darmawan, Ken Ng, Andrew Hung, Tom C. Karagiannis. CANDC, 87:107292, 2020. [doi]

in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assayEleni Pitsillou, Julia Liang, Chris Karagiannis, Katherine Ververis, Kevion K. Darmawan, Ken Ng, Andrew Hung, Tom C. Karagiannis. CANDC, 89:107408, 2020. [doi]

Sign in or sign up to see more results.

runs on WebDSL